News US regulator approves new use for Pfizer's Sutent FDA granted new kidney cancer indication despite advisers' split decision
Views & Analysis 7 questions: Bayer's Eugene Borukhovich Eugene Borukhovich's perspective on digital health and its future.
News NICE rejects Bayer and Eisai drugs in thyroid cancer Thyroid cancer drugs are available in Scotland and Wales
News Bayer left playing catch-up with BMS after Xarelto failure BMS' rival anticoagulant takes commanding market lead.
News NICE recommends Bayer drug for severe short-sightedness Eylea should be funded in mCNV, says NICE
News Bayer gains first Aliqopa approval in follicular lymphoma Bayer has gained FDA accelerated approval for its follicular lymphoma drug Aliqopa (copanlisib), giving it entry to the haemato-oncology market for the first time.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
